The Freedom of Scientific Research CONTEMPORARY ISSUES in BIOETHICS, LAW and MEDICAL HUMANITIES

Total Page:16

File Type:pdf, Size:1020Kb

The Freedom of Scientific Research CONTEMPORARY ISSUES in BIOETHICS, LAW and MEDICAL HUMANITIES The freedom of scientific research CONTEMPORARY ISSUES IN BIOETHICS, LAW AND MEDICAL HUMANITIES Contemporary Issues in Bioethics, Law and Medical Humanities, edited by Rebecca Bennett and Simona Giordano, of the University of Manchester, was established to publish internationally respected book-length works – primarily monographs and edited collections, but also specialist textbooks – in contemporary issues in bioethics, law and the medical humanities and as such welcomes proposals from this range of academic approaches to pertinent issues in this area. The series focuses on the strong foundations and reputation of the University of Manchester’s world-leading scholars in bioethics and law, and its internationally respected Centre for Social Ethics and Policy. Works from across the humanities, brought to bear on contem- porary, historical and indeed future bioethical questions of the highest social and moral concern and interest, will find a perfect home within this series. FROM REASON TO PRACTICE IN BIOETHICS An anthology dedicated to the works of John Harris Edited by John Coggon, Sarah Chan, Søren Holm and Thomasine Kushner Medicine, patients and the law: Sixth edition Margaret Brazier and Emma Cave Edited by Simona Giordano in collaboration with John Harris and Lucio Piccirillo The freedom of scientific research Bridging the gap between science and society Manchester University Press Copyright © Manchester University Press 2019 This electronic version has been made freely available under a Creative Commons (CC-BY-NC- ND) licence, which permits non-commercial use, distribution and reproduction provided the author(s) and Manchester University Press are fully cited and no modifications or adaptations are made. Details of the licence can be viewed at https://creativecommons.org/licenses/by-nc-nd/4.0/ Published by Manchester University Press Altrincham Street, Manchester M1 7JA www.manchesteruniversitypress.co.uk British Library Cataloguing-in-Publication Data A catalogue record for this book is available from the British Library ISBN 978 1 5261 2767 9 hardback First published 2019 The publisher has no responsibility for the persistence or accuracy of URLs for any external or third-party internet websites referred to in this book, and does not guarantee that any content on such websites is, or will remain, accurate or appropriate. Typeset by Toppan Best-set Premedia Limited to Nico Contents List of figures page ix List of tables x Notes on contributors xi Series editor’s foreword xvii Preface by John Harris xix Acknowledgements xxvi Part I – Freedom of science: promises and hazards Introduction to Part I 3 Simona Giordano 1 The influence of infection on society 19 Peter Lachmann 2 Scientific progress and longevity: curse or blessing? 32 Simona Giordano 3 Reproductive technologies and the family in the twenty-first century 57 Daniela Cutas and Anna Smajdor 4 New frontiers in surgery: the case of uterus and penis transplantation 71 Gennaro Selvaggi and Sean Aas 5 Freedom, law, politics, genes: the case of mitochondrial transfer 92 Iain Brassington 6 Scientific freedom and responsibility in a biosecurity context 105 Catherine Rhodes viii Contents 7 Robotic intelligence: philosophical and ethical challenges 121 David Lawrence 8 Big science and small science: reflections on the relationship between science and society from the perspective of physics 133 Lucio Piccirillo Part II – Freedom of science and the need for regulation Introduction to Part II 143 Simona Giordano 9 Advocating a radical change in policies and new models to secure freedom and efficiency in funding and communication of science 150 Andrea Ballabeni and Davide Danovi 10 Freedom of research and the right to science: from theory to advocacy 162 Andrea Boggio and Cesare P. R. Romano 11 The donation of embryos for research: maintaining trust 6 17 Heidi Mertes 12 From Galileo to embryos and narcotic drugs: the quest for the right to science 185 Marco Cappato 13 Science, self-control and human freedom: a naturalistic approach 201 Gilberto Corbellini and Elisabetta Sirgiovanni 14 Evidence-based policy and the precautionary principle: friends or foes? 212 Roberto Baldoli and Claudio M. Radaelli 15 Let freedom ring for science: an American perspective 220 Mary Woolley Conclusion 225 Simona Giordano Index 231 List of figures 1.1 A history of mortality page 21 4.1 Penile reconstruction with radial forearm flap 74 4.2 Donor-area morbidity (scarring) following the harvesting of a radial forearm flap for penile reconstruction 75 List of tables 1.1 Examples of human infectious diseases of animal origin page 20 1.2 The effectiveness of vaccines 23 Contributors Sean Aas is Senior Research Scholar at the Kennedy Institute of Ethics and Assistant Professor in the Philosophy Department at Georgetown University. His primary areas of research are bioethics, metaethics, and social and political philosophy, with a significant focus on issues of disability: disability as social construct, disability and political egalitarianism, disability and health. These interests tie to broader projects: on the nature and basis of our rights in our bodies; the grounds of egalitarian justice; and the import of diverse embodiment for healthcare ethics and health policy. Roberto Baldoli is Associate Lecturer at the University of Exeter, and a member of the Centre for European Governance. He received his PhD in politics from the University of Exeter in 2015. His main research interests revolve around theory and practice of nonviolence. In his PhD thesis, he reinterpreted nonviolence as an impure praxis, a non-systematic revolutionary approach aiming at freedom and plurality. Roberto is also interested in the European Union. He has published on different aspects of European politics, such as the European Citizens’ Initiative and the Spitzenkandidaten Procedure. Andrea Ballabeni is Clinical Program Leader at Chiesi Farmaceutici and Visiting Scientist at Harvard T. H. Chan School of Public Health. Ballabeni worked in molecular and cell biology basic research for several years, doing doctoral research at the European Institute of Oncology and postdoctoral research at the Harvard Medical School. He later shifted focus towards clinical and public health research as well as science policy. He then worked as Adjunct Assistant Professor of Natural and Applied sciences at Bentley University, teaching courses on human biology and doing research in the Center for Integration of Science and Industry. He is currently working as Clinical Program Leader at Chiesi Farmaceutici, and collaborating as a Visiting Scientist with the Harvard T. H. Chan School of Public Health (USA) on science policies to increase the quality and the output of scientific xii Contributors investigations. Ballabeni is also a science advocate and has collaborated with Associazione Luca Coscioni since 2006. He holds a PhD in molecular oncology from the Open University (UK), a master’s in public health from the Harvard T. H. Chan School of Public Health and an MSc in biology from the University of Parma (Italy). Andrea Boggio is Professor of Legal Studies at Bryant University. He is the author of Compensating Asbestos Victims. Law and the Dark Side of Industrialization (2013) and the co-editor of Health and Development: Toward a Matrix Approach (2009). He has extensively written on science policy issues. He earned a doctoral degree from Stanford University and completed his post-doc training at the University of Geneva. He taught at the Centre for Professional Ethics at Keele University (UK). Iain Brassington is a senior lecturer in the School of Law at the University of Manchester. A philosopher by training, his work covers many areas of applied ethics, with a particular focus on bioscience, and the interaction between ethics and law. His most recent book, Bioscience and the Good Life, was published in 2013; he is currently planning a book on the privacy or otherwise of genetic data. Iain is an editor of, and contributor to, the Journal of Medical Ethics blog; in 2016, he was invited to sit on the BMA’s Medical Ethics Committee. Marco Cappato is Coordinator of the World Congress for Freedom of Scientific Research, Treasurer of the Luca Coscioni Association and promoter of campaigns for the legalisation of euthanasia and illicit drugs in Italy, also through several civil disobedience actions. Cappato served as an MEP (1999–2004 and 2006–09). He has been European Parliament Rapporteur on: ‘privacy in electronic communication Directive’; ‘human rights in the world for 2007’; ‘production of opium for medical purposes in Afghanistan’; ‘public access to EU documents’. He was nominated for the Politician of the Year award organised by Wired magazine in 2003 in San Francisco and was winner of the European of the Year award organised by European Voice magazine in Brussels. Gilberto Corbellini is Full Professor of History of Medicine and Bioethics, and Director of the Museum of the History of Medicine in the Department of Molecular Medicine at Sapienza University of Rome. He has published several books, peer-reviewed and newspaper articles about the history of immunosciences, neuroscience, medical ethics and epistemology, and on science and politics. Recent books include: Perché gli scienziati non sono pericolosi (2009); Scienza quindi democrazia (2011); Scienza (2013); Tutta colpa del cervello (with E. Sirgiovanni, 2013); Bioetica per perplessi (2016). He is working with Elisabetta Sirgiovanni on a new book on the philosophy of evolutionary psychiatry.
Recommended publications
  • Genitourinary Membership Requirements Workgroup Meeting Summary February 17, 2021 Conference Call
    OPTN Vascularized Composite Allograft Transplantation Committee Genitourinary Membership Requirements Workgroup Meeting Summary February 17, 2021 Conference Call Nicole M. Johnson, MBA, RN, Co-Chair Stefan Tullius, MD, PhD, Co-Chair Introduction The Vascularized Composite Allograft (VCA) Transplantation Committee’s Genitourinary Membership Requirements Workgroup met via Citrix GoTo teleconference on 02/17/2021 to discuss the following agenda items: 1. Primary Surgeon Requirements The following is a summary of the Workgroup’s discussions. 1. Primary Surgeon Requirements The Workgroup discussed requirements for the primary surgeon of a genitourinary organ VCA transplant program. Summary of discussion: Overview of Primary Surgeon Requirements for Upper Limb & Head and Neck Transplant Programs The primary surgeon requirements for upper limb and head and neck transplant programs have three main components: (1) general requirements regarding degree, licensure, and credentialing, as well as observation of multi-organ procurements; (2) board certification requirement, which can be met by American board certification or an alternative to American board certification; and (3) experience requirements, which can be met though completion of an Accreditation Council for Graduate Medical Education (ACGME) fellowship; completion of another fellowship that meets OPTN criteria; or a minimum clinical experience pathway. The Co-Chair noted that there is no ACGME fellowship specific to genitourinary organ transplants and asked if that means the primary surgeon for a genitourinary organ transplant program can only qualify via the clinical experience pathway. UNOS staff said that the Workgroup had previously identified some appropriate fellowships for the experience requirement but the Workgroup could also work on defining a clinical experience pathway. A member said that for organs that have a low case volume, like intestine and VCA, having parallel paths to qualify may be the best approach to help new programs get started.
    [Show full text]
  • Academic Search Complete
    Academic Search Complete Pavadinimas Prenumerata nuo Prenumerata iki Metai nuo Metai iki 1 Technology times 2021-04-01 2021-12-31 20140601 20210327 2 Organization Development Review 2021-04-01 2021-12-31 20190101 3 PRESENCE: Virtual & Augmented Reality 2021-04-01 2021-12-31 20180101 4 Television Week 2021-04-01 2021-12-31 20030310 20090601 5 Virginia Declaration of Rights and Cardinal Bellarmine 2021-04-01 2021-12-31 6 U.S. News & World Report: The Report 2021-04-01 2021-12-31 20200124 7 Education Journal Review 2021-04-01 2021-12-31 20180101 8 BioCycle CONNECT 2021-04-01 2021-12-31 20200108 9 High Power Computing 2021-04-01 2021-12-31 20191001 10 Economic Review (Uzbekistan) 2021-04-01 2021-12-31 20130801 11 Civil Disobedience 2021-04-01 2021-12-31 12 Appeal to the Coloured Citizens of the World 2021-04-01 2021-12-31 13 IUP Journal of Environmental & Healthcare Law 2021-04-01 2021-12-31 14 View of the Revolution (Through Indian Eyes) 2021-04-01 2021-12-31 15 Narrative of Her Life: Mary Jemison 2021-04-01 2021-12-31 16 Follette's Platform of 1924 2021-04-01 2021-12-31 17 Dred Scott, Plaintiff in Error, v. John F. A. Sanford 2021-04-01 2021-12-31 18 U.S. News - The Civic Report 2021-04-01 2021-12-31 20180928 20200117 19 Supreme Court Cases: The Twenty-first Century (2000 - Present) 2021-04-01 2021-12-31 20 Geophysical Report 2021-04-01 2021-12-31 21 Adult Literacy 2021-04-01 2021-12-31 2000 22 Report on In-Class Variables: Fall 1987 & Fall 1992 2021-04-01 2021-12-31 2000 23 Report of investigation : the Aldrich Ames espionage case / Permanent Select Committee on Intelligence,2021-04-01 U.S.
    [Show full text]
  • Newsletter 8
    Fellowship Newsletter 8 Clinical Academic Medicine in Jeopardy Recruitment is in crisis and those already following a time for research, and proposes clinical academic career are under pressure as never solutions for the particular before. The attraction of a career in difficulties experienced in craft clinical academic medicine is specialties such as surgery, fading and while the public anaesthetics, obstetrics and have strong expectations for gynaecology, radiology, and high medical standards and cardiology. rapid developments in health- Professor Sir Peter Morris FRS, care more than 10% of PRCS, FMedSci, chairman of professorial and senior lecturer the Academy working group posts remain unfilled and the that produced the report said at shortage of clinical research its launch ‘The situation for workers and clinical teachers academic medicine is becoming desperate espe- raises serious worries. cially for craft specialties such as surgery. The Academy’s latest report Concerted action by all the stakeholders - the Clinical academic medicine in Academy, government, the universities, the medical jeopardy, confronts these issues, royal colleges and others - is needed now, not only to demands urgent action to improve recruitment and produce the next generation of doctors but also to retention and spells out the consequences of inaction. maintain the translation of basic biological research into It makes practical suggestions for how this can be clinical practice in the UK’. achieved by addressing contractual and remuneration The report may be downloaded from the Academy’s issues, and appraisal and revalidation practices, and web site or paper copies obtained free from Tony Leaney improving career progress. It stresses the importance at the Academy.
    [Show full text]
  • Indian S&T Journals in International Indexing and Abstracting Databases
    Annals of Library and Information Studies Vol. 59, December 2012, pp. 247-279 Indian S&T journals in international indexing and abstracting databases: A study Rabishankar Giri1, Prakash Chand2 and B K Sen3 1Indira Gandhi Institute of Technology, GGS Indraprastha University, Kashmere Gate, Delhi-110006, Email: [email protected], 2,aEx-Scientist, CSIR-National Institute of Science Communication and Information Resources, 14-Satsang Vihar Marg, New Delhi – 110067, Email: [email protected] 3,bFormer Visiting Professor, University of Malaya, Malaysia, Email: [email protected] The coverage of Indian science and technology (S&T) periodicals in major international indexing and abstracting (I&A) services has been studied. It is found that about 1200 Indian S&T journals are being covered by at least one of the international I&A services and over 300 S&T journals are openly accessible. However, coverage of Indian S&T journals by major citation databases, Web of Science (WoS) & Scopus is relatively poor. The newly launched Indian Citation Index (ICI) promises to cover more Indian journals. Keywords: Indian S&T journals, indexing & abstracting services, citation measure, impact factor Introduction Zoological Record, Excerpta Medica/Embase. India is the world's second fastest growing Medline, Index Copernicus, Mathematical Reviews, economy only next to China, with a large R & D Zentralblatt MATH, INIS, GeoBase along with two infrastructure. According to a recent report of Ernst & citation databases Scopus and Science Citation Index Young, India’s current higher education spending is Expanded (SCI-E) besides DOAJ to understand the estimated at Rs. 4,620 billion and projected to grow new open access phenomenon.
    [Show full text]
  • AMRITA HOSPITALS AMRITA AMRITA HOSPITALS HOSPITALS Kochi * Faridabad (Delhi NCR) Kochi * Faridabad (Delhi NCR)
    AMRITA HOSPITALS HOSPITALS AMRITA AMRITA AMRITA HOSPITALS HOSPITALS Kochi * Faridabad (Delhi NCR) Kochi * Faridabad (Delhi NCR) A Comprehensive A Comprehensive Overview Overview A Comprehensive Overview AMRITA INSTITUTE OF MEDICAL SCIENCES AIMS Ponekkara P.O. Kochi, Kerala, India 682 041 Phone: (91) 484-2801234 Fax: (91) 484-2802020 email: [email protected] website: www.amritahospitals.org Copyright@2018 AMRITA HOSPITALS Kochi * Faridabad (Delhi-NCR) A COMPREHENSIVE OVERVIEW A Comprehensive Overview Copyright © 2018 by Amrita Institute of Medical Sciences All rights reserved. No portion of this book, except for brief review, may be reproduced, stored in a retrieval system, or transmitted in any form or by any means —electronic, mechanical, photocopying, recording, or otherwise without permission of the publisher. Published by: Amrita Vishwa Vidyapeetham Amrita Institute of Medical Sciences AIMS Ponekkara P.O. Kochi, Kerala 682041 India Phone: (91) 484-2801234 Fax: (91) 484-2802020 email: [email protected] website: www.amritahospitals.org June 2018 2018 ISBN 1-879410-38-9 Amrita Institute of Medical Sciences and Research Center Kochi, Kerala INDIA AMRITA HOSPITALS KOCHI * FARIDABAD (DELHI-NCR) A COMPREHENSIVE OVERVIEW 2018 Amrita Institute of Medical Sciences and Research Center Kochi, Kerala INDIA CONTENTS Mission Statement ......................................... 04 Message From The Director ......................... 05 Our Founder and Inspiration Sri Mata Amritanandamayi Devi .................. 06 Awards and Accreditations .........................
    [Show full text]
  • The History of Microsurgery in Urological Practice
    Chen-1 The History of Microsurgery in Urological Practice Mang L. Chen1, Gregory M. Buncke2 and Paul J. Turek3 1G.U. Recon, San Francisco, CA, 94114 2The Buncke Clinic, San Francisco, CA 94114 3The Turek Clinic, Beverly Hills, CA 90210 Correspondence to: Mang Chen, MD G.U. Recon 45 Castro St, Suite 111 San Francisco, CA 94114 Tel: 415-481-3980 Email: [email protected] Chen-2 Abstract Operative microscopy spans all surgical disciplines, allowing human dexterity to perform beyond direct visual limitations. Microsurgery started in otolaryngology, became popular in reconstructive microsurgery, and was then adopted in urology. Starting with reproductive tract reconstruction of the vas and epididymis, microsurgery in urology now extends to varicocele repair, sperm retrieval, penile transplantation and free flap phalloplasty. By examining the peer reviewed and lay literature this review discusses the history of microsurgery and its subsequent development as a subspecialty in urology. Keywords: urology, microsurgery, phalloplasty, vasovasostomy, varicocelectomy Chen-3 I. Introduction Microsurgery has been instrumental to surgical advances in many medical fields. Otolaryngology, ophthalmology, gynecology, hand and plastic surgery have all embraced the operating microscope to minimize surgical trauma and scar and to increase patency rates of vessels, nerves and tubes. Urologic adoption of microsurgery began with vasectomy reversals, testis transplants, varicocelectomies and sperm retrieval and has now progressed to free flap phalloplasties and penile transplantation. In this review, we describe the origins of microsurgery, highlight the careers of prominent microsurgeons, and discuss current use applications in urology. II. Birth of Microsurgery 1) Technology The birth of microsurgery followed from an interesting marriage of technology and clinical need.
    [Show full text]
  • Joint Statement on Public Disclosure of Results from Clinical Trials
    Joint statement on public disclosure of results from clinical trials Signatories on 18 May 2017 Indian Council of Medical Research Research Council of Norway UK Medical Research Council Médecins Sans Frontières Epicentre CEPI PATH Institut Pasteur Bill and Melinda Gates Foundation Wellcome Trust Introduction The current 2013 Declaration of Helsinki states that “Every research study involving human subjects must be registered in a publicly accessible database before recruitment of the first subject.” and that “Researchers have a duty to make publicly available the results of their research .... Negative and inconclusive as well as positive results must be published or otherwise made publicly available”. In addition to the ethical imperative, poor allocation of resources for product development and financing of available interventions, and suboptimal regulatory and public health recommendations may occur where decisions are based on only a subset of all completed clinical trials. The signatories of this joint statement affirm that the prospective registration and timely public disclosure of results from all clinical trials is of critical scientific and ethical importance. Furthermore timely results disclosure reduces waste in research, increases value and efficiency in use of funds and reduces reporting bias, which should lead to better decision-making in health. Within 12 months of becoming a signatory of this statement, we each pledge to develop and implement a policy with mandated timeframes for prospective registration and public disclosure of the results of clinical trials that we fund, co-fund, sponsor or support. We each agree to monitor registration and endorse the development of systems to monitor results reporting on an ongoing basis.
    [Show full text]
  • Tribune Spring 2015
    Tribune ...and its Sections Cell Transplant Society | International Hand and Composite Tissue Allotransplantation Society International Pancreas & Islet Transplant Association | International Pediatric Transplant Association | International Society for Organ Donation and Procurement International Xenotransplantation Association | Intestinal Transplant Association | Transplant Infectious Disease Spring 2015 • Volume XII • Issue I OFFICIAL NEWSLETTER OF THE TRANSPLANTATION SOCIETY President’sPresident’s MessageMessage ININ THISTHIS ISSUE COMINGCOMING intointo FOCUS PROJECT FOCUS 8 NOTIFY FURTHERING OUR MISSION OF SCIENCE, EDUCATION AND PUBLIC POLICY NEW TURKISH 9 SOCIETY Membership and Anniversary Committee Updates Celebration beginning on page 10 19 6 66 201 Section Updates beginning on page 21 THE FIFTH DECADE OF INTERNATIONAL COOPERATION, INNOVATION, GROWTH AND PROGRESS TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible: PRESIDENT’S MESSAGE new initiatives to reinvigorate interest in our specialty and allow transplant patients to Philip J. O’Connell gain from the TTS President future benefits of personalized medicine n April I had the pleasure of attending the 20th Anniversary meeting of the Hong Kong Society of Transplantation. Although a relatively small group, they have been leaders in medical education and transplant medicine within Asia. Also present was Vasant Sumethkul, Kriengsak Vareesangthip and other members of the Thai Transplantation Society Council in a spirit of co-operation for the upcoming 2016 meeting. Whilst at the meeting, I had the opportunity to meet with the local liaison committee to discuss plans for the upcoming international congress of our Society that will be held in Hong Kong in 2016. Plans are well advanced and all the relevant committees have been set up and tasks allocated.
    [Show full text]
  • Transparency in the Time of Constant Change
    PhUSE 2014 Paper RG02 Transparency in the Time of Constant Change Todd Case, Biogen Idec, Cambridge MA, USA ABSTRACT The time has come, after years of hard work, to submit your application to the regulatory agency for review and possible approval! What a relief to be able to finally hand off all of your hard work and, wait a minute, ensure that all data can be reproducible?!? While CDISC has been widely adopted and its SDTM and AdAM models widely implemented, there is still the need to understand the process of ensuring that all the data is a reflection of how it was originally collected, which in some cases can be very challenging. This paper will discuss some more trending ways of both creating and presenting data in ways that ensure it is consumable and can be understood not only for analysis/submission purposes but also that post-approval it is transparent and that everyone who has a vested stake can review the data in an appropriate way. INTRODUCTION With the publication of Bad Pharma: How Medicine is Broken , and How We Can Fix it, by Dr. Ben Goldacre in 2013 a bright spotlight was shone on the data behind/supporting clinical trials. A large part of his thesis is that pharmaceutical companies exaggerate the efficacy of successful trials and that, in addition to drug companies, regulators , physicians (who are educated by the drug companies) and even patient groups have failed to protect us. Another rather striking revelation was that a clinical trial with positive results is twice more likely to be published than one with negative results (although it should be noted that this specifically is related to results – the protocol is always provided).
    [Show full text]
  • Patents, Partnerships, and the Pre-Competitive Collaboration Myth in Pharmaceutical Innovation
    Patents, Partnerships, and the Pre-Competitive Collaboration Myth in Pharmaceutical Innovation Liza S. Vertinsky* Public-private partnerships offer a promising alternative paradigm for pharmaceutical innovation in complex disease areas where there are both strong commercial interests and significant public need. They have the potential to reduce the tremendous waste associated with duplicative unsuccessful drug development efforts and to encourage the sharing of knowledge essential to accelerate pharmaceutical innovation. Patents threaten the potential of partnership strategies, however, by making it harder to sustain robust systems of knowledge sharing. Policymakers have tried to avoid this problem by focusing partnership strategies on areas deemed to be pre-competitive — areas of collaboration without competition and typically also without patents. This Article suggests that the current pre-competitive approach to partnership strategies in pharmaceutical innovation is fundamentally flawed for two reasons. First, it ignores the competitive market pressures that both shape what is deemed to be pre-competitive and fuel tensions * Copyright © 2015 Liza S. Vertinsky. Associate Professor of Law, Emory University School of Law. Many thanks to Timothy Holbrook, Timothy Terrell, Yaniv Heled, Cynthia Ho, Kevin Outterson, and Michael Carroll, as well as Sean O’Connor, Roger Ford, Dan Burk, Mark McKenna, and other participants of the Yale Innovation Beyond IP conference 2014; Arti Rai, Jerome Reichman, Katherine Strandburg, Brett Frischmann, Michael Madison, Peter Lee, Margaret Chon, Sonali Shah, and the other participants in the Medical Commons Workshop at NYU in May 2014 and the 2nd Thematic Conference on the Knowledge Commons at NYU in September 2014; participants in the summer workshop at Georgia State College of Law in July 2014; participants of the Emory Faculty Colloquium; Simon Stern, Abraham Drassinower, Margaret J.
    [Show full text]
  • Report on Transparency and Registration in Clinical Research In
    Transparency and Registration in Clinical Research in the Nordic Countries By the Nordic Trial Alliance Working Group on Transparency and Registration Transparency and Registration in Clinical Research in the Nordic Countries Nordic Trial Alliance NordForsk Stensberggata 25 NO-0170 Oslo www.nta.nordforsk.org Design: jnd.no Printed by: 07 Group ISSN 1504-8640 ER JØM KE IL T M 2 4 9 1 7 3 Trykksak Transparency and Registration in Clinical Research in the Nordic Countries By the Nordic Trial Alliance Working Group on Transparency and Registration 1 Table of Contents Preface 4 The Nordic Trial Alliance Working Group on Transparency and Registration 6 Conflicts of Interest 7 Abbreviations 8 1. Executive summary 16 2. Background 20 3. Introduction to transparency 30 4. International policies and regulations impacting the future of transparency 36 4.1 The Declaration of Helsinki 36 4.2 The Food and Drug Administration Amendments Act of 2007 36 4.3 The European Clinical Research Infrastructures Network (ECRIN) 37 4.4 European Medicines Agency 37 4.5 Horizon 2020 38 4.6 Regulation on clinical trials on medicinal product for human use 39 4.7 EU Regulation for data protection 40 5. Arguments in favour of and against transparency 44 5.1 Arguments in favour 44 5.2 Arguments against 49 6. Does publication of trial protocols or trial results in registers impede journal publications? 54 7. Registries and repositories 58 2 8. Status of the Nordic countries 62 8.1 Current national procedures for public, prospective registration and reporting of clinical
    [Show full text]
  • Medical Practice, Psychiatry and the Pharmaceutical Industry : and Ever the Trio Shall Meet
    The Academia - Industry Symposium Medical Practice, Psychiatry and the Pharmaceutical Industry : And Ever the Trio Shall Meet i The Academia - Industry Symposium Medical Practice, Psychiatry and the Pharmaceutical Industry : And Ever the Trio Shall Meet Ajai R. Singh, M.D. Shakuntala A. Singh Ph.D THE GOAL Mens Sana Research Foundation Mumbai, India iii ISSN 0973-1229 © Mens Sana Monographs (2005) Vol II, No. 6; Vol III, No.1-3, March 2005 - October 2005. Ajai R. Singh, M.D., Psychiatrist. Earlier, Hon. Editor, Psychology and Human Behaviour Digest, and Senior Research Fellow, WHO Collaborating Center in Psychopharmacology in India. Shakuntala A. Singh, Ph.D. Reader and Head, Department of Philosophy, Joshi- Bedekar College, Thane. Earlier, Fellow, Indian Council of Philosophical Research, New Delhi. Mens Sana Monographs are published bimonthly. This issue equals four regular issues. No part of this Monograph may be reproduced in any form without the written permission of the editors, except as brief quotations for the sake of scientific communication, and with due acknowledgment. About us The Mens Sana Monographs attempt to give in-depth understanding of Psychiatric/ Psychological/Philosophical consequences of social disorders / issues and current events, written in an easy to read format, avoiding technical jargon as far as possible, but based on evidence and research studies. Every monograph is to be followed by enlightened discussion on the issues raised by interested readers / scholars. You may forward your views / comments to the editors for incorporation, which may be suitably modified wherever necessary. The Mens Sana Monographs provide a wide platform for serious discussion by psychiatrists, social scientists, philosophers, psychologists, sociologists and other thinkers interested in exploring social issues with scientific rigour.
    [Show full text]